HD 16 - Städtisches Klinikum Magdeburg

Literatur
Radford JA, Crowther D, Rohatiner AZ et al. Results of a randomized trial comparing MVPP chemo-
therapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease. J
Clin Oncol 1995 Sept.; 13(9):2379-85
Radford J, O´Doherty M, Barrington S et al. Results of the 2 nd planned interim analysis of the RAPID
trial (involved field radiotherapy versus no further treatment) in patients with clinical stages 1A
and 2A Hodgkin lymphoma with a negative FDG-PET scan after 3 cycles ABVD Blood 2008:
112(11: abstract 369
Rüffer U, Josting A, Franklin J, et al. Non-Hodgkin Lymophoma after primary Hodgkin´s disease in the
GHSG. Incidence, treatment and prognosis. J Clin Oncol 19(7):2026-32, 2001
Rüffer JU, Schiller P, Sieber M et al. Hodgkin's lymphoma in the elderly - experience of the GHSG.
Leukemia & Lymphoma 42 Suppl.2: p103-104, 2001
Santoro A, Bredenfeld H, Devizzi L et al. Gemcitabine in the treatment of refractory Hodgkin's disease:
results of a multicenter phase II study. J Clin Oncol 2000 July; 18(13):2615-9
Schellong G: The balance between cure and late effects in childhood Hodgkin´s lymphoma: The experience
of the German-Austrian Study-Group since 1978. Ann Oncol 7: 67-72, 1996
Schmitz N, Pfistner B, Sextro M et al. for the German Hodgkin´s Lymphoma Study Group (GHSG) and
the Working Party Lymphoma of the European Group for Blood and Marrow Transplantation
(EBMT): Aggressive conventional chemotherapy compared with high-dose chemotherapy requiring
autologous hematopoietic stem cell transplantation for relapsed chemosensitive Hodgkin´s
disease. The Lancet 359: 2065-2071, 2002
Schoenfeld DA, Richter JR. Nomograms for Calculating the Number of Patients Needed for a Clinical
Trial With Survival as an Endpoint. Biometrics 38, 163-170. 1982
Shapiro SJ, Shapiro SD, Mill WB, et al.: Prospective study of long-term pulmonary manifestations of
mantle irradiation. Int J Rad Oncol; 19: 707-714, 1990
Sieber M, Tesch H, Pfistner B et al. Rapidly Alternating COPP/ABV/IMEP Is Not Superior to Conventional
Alternating COPP/ABVD in Combination With Extended-Field Radiotherapy in Intermediate-Stage
Hodgkin's Lymphoma: Final Results of the German Hodgkin's Lymphoma Study
Group Trial HD5. J Clin Oncol 20: 476-484, 2002
Smets EMA, Garsson B, Bonke B et al.. The Multidimensional Fatigue Inventory (MFI); Psychometric
qualities of an instrument to assess fatigue, J Psychosom Res, 39, 315-325, 1995
Smets EMA, Garsson B, Cull A, et al. Application of the Multidimensional Fatigue Inventory (MFI-20) in
cancer patients receiving radiotherapy, Br J Cancer 73:241-245, 1996
- GHSG - HD16-Studienprotokoll (10/2009 – V3.0) - 127